0000899243-17-008658.txt : 20170327
0000899243-17-008658.hdr.sgml : 20170327
20170327173334
ACCESSION NUMBER: 0000899243-17-008658
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170323
FILED AS OF DATE: 20170327
DATE AS OF CHANGE: 20170327
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MyoKardia Inc
CENTRAL INDEX KEY: 0001552451
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 455500552
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 333 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-741-0900
MAIL ADDRESS:
STREET 1: 333 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McDowell Robert Scott
CENTRAL INDEX KEY: 0001412376
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37609
FILM NUMBER: 17716272
MAIL ADDRESS:
STREET 1: 341 OYSTER POINT BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-03-23
0
0001552451
MyoKardia Inc
MYOK
0001412376
McDowell Robert Scott
C/O MYOKARDIA, INC.
333 ALLERTON AVENUE
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
See Remarks
Stock Option (Right to Buy)
1.51
2017-03-23
4
A
0
6803
0.00
A
2017-03-23
2025-06-03
Common Stock
6803
13606
D
On June 4, 2015, the Reporting Person was granted an option to purchase 27,211 shares of Common Stock under the issuer's 2012 Equity Incentive Plan, the vesting of which was subject to various conditions (other than the passage of time and continued employment) that were not tied to the market price of the issuer's securities. On March 23, 2017, one of the conditions was deemed to be achieved, resulting in the vesting and exercisability of 6,803 of the shares underlying such option.
Senior Vice President, Drug Discovery
/s/ Jake Bauer, as Attorney-in-Fact
2017-03-27